A Multi-Objective Approach Optimizing Pharmacy Industry Decisions through MOORA Method

{"title":"A Multi-Objective Approach Optimizing Pharmacy Industry Decisions through MOORA Method","authors":"","doi":"10.46632/daai/4/1/1","DOIUrl":null,"url":null,"abstract":"The pharmacy industry, a crucial pillar of the healthcare sector, encompasses the discovery, development, production, distribution, and sale of pharmaceutical drugs and medications. With an intricate interplay of scientific innovation, medical expertise, and commercial activities, this industry plays an indispensable role in safeguarding and improving human health. From the inception of groundbreaking drugs to their widespread distribution, the pharmacy industry integrates various stakeholders, including pharmaceutical companies, researchers, healthcare professionals, regulators, and consumers. It strives to address a wide spectrum of health conditions, from acute ailments to chronic diseases, by developing innovative treatments, generic medicines, and over-the-counter drugs. The pharmacy industry's evolution has been marked by technological advancements, research breakthroughs, and regulatory frameworks to ensure drug safety and efficacy. As the global population continues to grow and age, the industry faces the challenges of maintaining affordability, accessibility, and quality of medications. Furthermore, the pharmacy industry is a catalyst for economic growth, creating jobs, fostering research collaborations, and contributing to national and international healthcare systems. Its multifaceted nature, ranging from drug research to patient care, underscores its significance in the broader landscape of healthcare and public well-being. Research within the pharmacy industry holds immense significance due to its pivotal role in advancing medical knowledge and improving patient outcomes. Pharmaceutical research drives the development of new medications, innovative therapies, and treatment protocols, enhancing the efficacy and safety of drugs. It also uncovers insights into disease mechanisms, fostering a deeper understanding of health conditions. Furthermore, research guides regulatory decisions, ensuring drugs' quality, and promotes evidence-based medical practices. Through ongoing investigation, the pharmacy industry continually evolves, addressing emerging health challenges, optimizing drug utilization, and ultimately contributing to the overall enhancement of global healthcare standards. MOORA (Multi-Objective Optimization by Ratio Analysis) is a decision-making method used to evaluate and prioritize alternatives based on multiple conflicting criteria. It involves comparing alternatives' performance ratios against reference alternatives, considering both benefits and drawbacks. By assigning weights to criteria, MOORA quantifies their importance and ranks alternatives accordingly. This technique assists in complex decision scenarios where various factors must be balanced. MOORA's systematic approach aids in reaching well-informed decisions by quantifying trade-offs and providing a structured framework for considering multiple objectives simultaneously. Product Innovation, Market Share (%), Research Investment ($ billion), Patient Satisfaction, Drug Efficacy (%), Global Reach (countries). Pfizer, Johnson & Johnson, Roche, Novartis, GlaxoSmithKline, CVS Health, Walgreens Boots Alliance, Rite Aid.From the result it is seen that Novartisis got the first rank where as is the Rite Aidis having the lowest rank.","PeriodicalId":226827,"journal":{"name":"Data Analytics and Artificial Intelligence","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Data Analytics and Artificial Intelligence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46632/daai/4/1/1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The pharmacy industry, a crucial pillar of the healthcare sector, encompasses the discovery, development, production, distribution, and sale of pharmaceutical drugs and medications. With an intricate interplay of scientific innovation, medical expertise, and commercial activities, this industry plays an indispensable role in safeguarding and improving human health. From the inception of groundbreaking drugs to their widespread distribution, the pharmacy industry integrates various stakeholders, including pharmaceutical companies, researchers, healthcare professionals, regulators, and consumers. It strives to address a wide spectrum of health conditions, from acute ailments to chronic diseases, by developing innovative treatments, generic medicines, and over-the-counter drugs. The pharmacy industry's evolution has been marked by technological advancements, research breakthroughs, and regulatory frameworks to ensure drug safety and efficacy. As the global population continues to grow and age, the industry faces the challenges of maintaining affordability, accessibility, and quality of medications. Furthermore, the pharmacy industry is a catalyst for economic growth, creating jobs, fostering research collaborations, and contributing to national and international healthcare systems. Its multifaceted nature, ranging from drug research to patient care, underscores its significance in the broader landscape of healthcare and public well-being. Research within the pharmacy industry holds immense significance due to its pivotal role in advancing medical knowledge and improving patient outcomes. Pharmaceutical research drives the development of new medications, innovative therapies, and treatment protocols, enhancing the efficacy and safety of drugs. It also uncovers insights into disease mechanisms, fostering a deeper understanding of health conditions. Furthermore, research guides regulatory decisions, ensuring drugs' quality, and promotes evidence-based medical practices. Through ongoing investigation, the pharmacy industry continually evolves, addressing emerging health challenges, optimizing drug utilization, and ultimately contributing to the overall enhancement of global healthcare standards. MOORA (Multi-Objective Optimization by Ratio Analysis) is a decision-making method used to evaluate and prioritize alternatives based on multiple conflicting criteria. It involves comparing alternatives' performance ratios against reference alternatives, considering both benefits and drawbacks. By assigning weights to criteria, MOORA quantifies their importance and ranks alternatives accordingly. This technique assists in complex decision scenarios where various factors must be balanced. MOORA's systematic approach aids in reaching well-informed decisions by quantifying trade-offs and providing a structured framework for considering multiple objectives simultaneously. Product Innovation, Market Share (%), Research Investment ($ billion), Patient Satisfaction, Drug Efficacy (%), Global Reach (countries). Pfizer, Johnson & Johnson, Roche, Novartis, GlaxoSmithKline, CVS Health, Walgreens Boots Alliance, Rite Aid.From the result it is seen that Novartisis got the first rank where as is the Rite Aidis having the lowest rank.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过 MOORA 方法优化制药业决策的多目标方法
制药业是医疗保健行业的重要支柱,包括药品和药物的发现、开发、生产、分销和销售。科学创新、医学专业知识和商业活动错综复杂地交织在一起,该行业在保障和改善人类健康方面发挥着不可或缺的作用。从开创性药物的诞生到其广泛销售,制药业整合了各利益相关方,包括制药公司、研究人员、医疗保健专业人员、监管机构和消费者。它通过开发创新疗法、非专利药品和非处方药,努力解决从急性病到慢性病的各种健康问题。药剂行业的发展以技术进步、研究突破和监管框架为标志,以确保药物的安全性和有效性。随着全球人口的不断增长和老龄化,该行业面临着保持药品的可负担性、可获得性和质量的挑战。此外,药学行业还是经济增长的催化剂,它能创造就业机会,促进研究合作,并为国家和国际医疗保健系统做出贡献。从药物研究到病人护理,药剂学的多面性凸显了它在更广泛的医疗保健和公众福祉中的重要性。药学行业内的研究工作在推动医学知识发展和改善患者治疗效果方面发挥着举足轻重的作用,因此意义重大。药学研究推动了新药、创新疗法和治疗方案的开发,提高了药物的疗效和安全性。它还能揭示疾病机理,加深对健康状况的了解。此外,研究还能指导监管决策,确保药品质量,促进循证医疗实践。通过持续的研究,药学行业不断发展,应对新出现的健康挑战,优化药物使用,最终为全面提高全球医疗保健标准做出贡献。MOORA(比率分析法多目标优化)是一种决策方法,用于根据多个相互冲突的标准对备选方案进行评估和优先排序。它包括将替代品的性能比与参考替代品进行比较,同时考虑其优点和缺点。通过给标准分配权重,MOORA 可以量化这些标准的重要性,并据此对备选方案进行排序。这种技术有助于在必须平衡各种因素的复杂决策场景中使用。MOORA 的系统方法通过量化权衡,为同时考虑多个目标提供了一个结构化框架,有助于在充分知情的情况下做出决策。产品创新、市场份额(%)、研究投资(亿美元)、患者满意度、药物疗效(%)、全球影响力(国家)。辉瑞、强生、罗氏、诺华、葛兰素史克、CVS Health、沃尔格林博姿联盟、Rite Aid。从结果可以看出,诺华排名第一,而 Rite Aid 排名最低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Smart Home Automation Digital Assistant for Video KYC Framework in India Enhancing House Price Predictability: A Comprehensive Analysis of Machine Learning Techniques for Real Estate and Policy Decision-Making Analysis of Machine Learning Models for Hate Speech Detection in Online Content Detection of Diabetic Retinopathy Using KNN & SVM Algorithm
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1